Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

INDIA: WHO Issues Guide For New TB Drug




 

Times of India (06.14.2013)
 
For the first time in 40 years, the World Health Organization (WHO) has issued interim guidance for the use of a new TB drug, bedaquiline, in the combination therapy for multi-drug resistant TB. The US Food and Drug Administration approved the drug last year. WHO’s interim guidance listed five conditions that must be in place if the new drug is to be used. Those conditions included close monitoring for effectiveness and safety, proper patient inclusion, informed consent, adherence to WHO recommendations, ensuring early detection and management of adverse drug reactions and potential interactions with other drugs.



 


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in June 17, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.